Literature DB >> 29296908

The case for HLA-identical sibling hematopoietic stem cell transplantation in children with symptomatic sickle cell anemia.

Courtney D Fitzhugh1, Mark C Walters2.   

Abstract

This article has a companion Counterpoint by DeBaun and Clayton.

Entities:  

Year:  2017        PMID： 29296908      PMCID： PMC5728630          DOI： 10.1182/bloodadvances.2017007708

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


  57 in total

1.  Modern total hip arthroplasty in patients younger than 21 years.

Authors:  Atul F Kamath; Neil P Sheth; Harish H Hosalkar; Oladapo M Babatunde; Gwo-Chin Lee; Charles L Nelson
Journal:  J Arthroplasty       Date:  2011-07-01       Impact factor: 4.757

2.  Transfusions for silent cerebral infarcts in sickle cell anemia.

Authors:  Michael R DeBaun; James F Casella
Journal:  N Engl J Med       Date:  2014-11-06       Impact factor: 91.245

3.  Renal Failure in Sickle Cell Disease: Prevalence, Predictors of Disease, Mortality and Effect on Length of Hospital Stay.

Authors:  Sri L H Yeruva; Yonette Paul; Patricia Oneal; Mehdi Nouraie
Journal:  Hemoglobin       Date:  2016-09-18       Impact factor: 0.849

4.  Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease.

Authors:  M Bhatia; Z Jin; C Baker; M B Geyer; K Radhakrishnan; E Morris; P Satwani; D George; J Garvin; G Del Toro; W Zuckerman; M T Lee; M Licursi; R Hawks; E Smilow; L A Baxter-Lowe; J Schwartz; M S Cairo
Journal:  Bone Marrow Transplant       Date:  2014-05-05       Impact factor: 5.483

5.  Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial.

Authors:  A Ferster; C Vermylen; G Cornu; M Buyse; F Corazza; C Devalck; P Fondu; M Toppet; E Sariban
Journal:  Blood       Date:  1996-09-15       Impact factor: 22.113

6.  Impact of hydroxyurea on clinical events in the BABY HUG trial.

Authors:  Courtney D Thornburg; Beatrice A Files; Zhaoyu Luo; Scott T Miller; Ram Kalpatthi; Rathi Iyer; Phillip Seaman; Jeffrey Lebensburger; Ofelia Alvarez; Bruce Thompson; Russell E Ware; Winfred C Wang
Journal:  Blood       Date:  2012-08-22       Impact factor: 22.113

7.  Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.

Authors:  Matthew M Hsieh; Courtney D Fitzhugh; R Patrick Weitzel; Mary E Link; Wynona A Coles; Xiongce Zhao; Griffin P Rodgers; Jonathan D Powell; John F Tisdale
Journal:  JAMA       Date:  2014-07-02       Impact factor: 56.272

8.  Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.

Authors:  Eliane Gluckman; Barbara Cappelli; Francoise Bernaudin; Myriam Labopin; Fernanda Volt; Jeanette Carreras; Belinda Pinto Simões; Alina Ferster; Sophie Dupont; Josu de la Fuente; Jean-Hugues Dalle; Marco Zecca; Mark C Walters; Lakshmanan Krishnamurti; Monica Bhatia; Kathryn Leung; Gregory Yanik; Joanne Kurtzberg; Nathalie Dhedin; Mathieu Kuentz; Gerard Michel; Jane Apperley; Patrick Lutz; Bénédicte Neven; Yves Bertrand; Jean Pierre Vannier; Mouhab Ayas; Marina Cavazzana; Susanne Matthes-Martin; Vanderson Rocha; Hanadi Elayoubi; Chantal Kenzey; Peter Bader; Franco Locatelli; Annalisa Ruggeri; Mary Eapen
Journal:  Blood       Date:  2016-12-13       Impact factor: 22.113

9.  Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies.

Authors:  Allison A King; Naynesh Kamani; Nancy Bunin; Indira Sahdev; Joel Brochstein; Robert J Hayashi; Michael Grimley; Allistair Abraham; Jacqueline Dioguardi; Ka Wah Chan; Dorothea Douglas; Roberta Adams; Martin Andreansky; Eric Anderson; Andrew Gilman; Sonali Chaudhury; Lolie Yu; Jignesh Dalal; Gregory Hale; Geoff Cuvelier; Akshat Jain; Jennifer Krajewski; Alfred Gillio; Kimberly A Kasow; David Delgado; Eric Hanson; Lisa Murray; Shalini Shenoy
Journal:  Am J Hematol       Date:  2015-10-06       Impact factor: 10.047

10.  Daily functioning and quality of life in children with sickle cell disease pain: relationship with family and neighborhood socioeconomic distress.

Authors:  Tonya M Palermo; Craig A Riley; Brian A Mitchell
Journal:  J Pain       Date:  2008-06-12       Impact factor: 5.820
View more
  4 in total

1.  Optimal disease management and health monitoring in adults with sickle cell disease.

Authors:  Jo Howard; Swee Lay Thein
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 2.  How I treat the older adult with sickle cell disease.

Authors:  Swee Lay Thein; Jo Howard
Journal:  Blood       Date:  2018-09-11       Impact factor: 22.113

Review 3.  Genetic therapies for the first molecular disease.

Authors:  Phillip A Doerfler; Akshay Sharma; Jerlym S Porter; Yan Zheng; John F Tisdale; Mitchell J Weiss
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

Review 4.  Haploidentical bone marrow transplant with posttransplant cyclophosphamide for sickle cell disease: An update.

Authors:  Dilan A Patel; Adeseye M Akinsete; Josu de la Fuente; Adetola A Kassim
Journal:  Hematol Oncol Stem Cell Ther       Date:  2020-03-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.